Abstract:After birth, most newborn mouse cardiomyocytes (CM) undergo a final cycle of cell division in the absence of cytokinesis, which leads to binucleation. The majority of subsequent increases in cardiac mass are attributable to cardiomyocyte hypertrophy, as a negligible number of new CM are created after birth. Mice with a heart-specific deletion of Dicer, a crucial enzyme necessary for microRNA maturation, die by the fifth postnatal day in spite of having normal cardiac morphology and function at birth. Despite the significance of this phenomenon, little is known about the molecular/genetic foundation for the change from hyperplastic to hypertrophic-based myocardial expansion that occurs in the neonatal mouse heart. We hypothesize that a microRNA is required for the normal transition from fetal to adult heart during the neonatal period. Heart microRNA profiles (3 arrays/time point) were measured from RNA was isolated from E19, 1, 3, 5, 7, 10, and 35-day-old mouse hearts (9 hearts/time point pooled). Bioinformatic analysis identified microRNA-205 as a possible participant in the cardiac transitional program. We observed a transient 20-fold increase in miR205 expression between postnatal days 1 and 5, with levels returning to baseline by day 10. In-situ hybridization revealed miR-205 expression is restricted to the heart's epicardium.We next generated mice with a CM-specific deletion of miR205 using MHCcre targeting of a floxed-miR205 allele. Mice lacking miR-205 in their CM appear normal at birth. Elevated cell cycle markers (Ki67 & phospho-pH3) were detected at postnatal day-14 with 20% larger hearts at postnatal day 14, and adult hearts measuring up to 50% larger than controls. In contrast, a CM-specific miR205 over-expression mouse model resulted in more CM being present at both 5-day and 14-day post-birth. Interestingly, no difference in cell-cycle markers or heart size was observed. miR205 directly targets YAP within the evolutionarily conserved hippo pathway, which regulates organ size. YAP protein expression is significantly increased in hearts lacking miR205. Both of the miR205-heart models present with altered Hippo signaling kinetics after birth. We conclude that miR205 regulates postnatal heart size by directly modulating the Hippo pathway.

Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2

Cardiac Hypertrophy and Dysfunction Induced by Overexpression of Mir-214 in Vivo

Microrna Networks In Mouse Lung Organogenesis

Abstract 19722: Cardiac Deletion of miRNA-17-92 Cluster Augments Acute Myocardial Ischemia-Reperfusion Injury

MicroRNAs: Novel Regulators of the Heart.

miRNA-204 drives cardiomyocyte proliferation via targeting Jarid2

Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice

Target-directed Microrna Degradation Regulates Developmental Microrna Expression and Embryonic Growth in Mammals.

Dgcr8 Deletion in the Primitive Heart Uncovered Novel Microrna Regulating the Balance of Cardiac-Vascular Gene Program.

Abstract P3037: MicroRNA-205 Is Required For Normal Cell Cycle And Cardiac Growth In The Neonatal Mouse Heart.

Inducible and reversible inhibition of miRNA-mediated gene repression in vivo

Micrornas in Cardiovascular Development

MicroRNAs: novel regulators in cardiac development and disease

Dynamic Microrna Expression Programs During Cardiac Differentiation of Human Embryonic Stem Cells Role for Mir-499

Cardiovascular dysregulation of miR‐17‐92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis

Global Mirna Dosage Control of Embryonic Germ Layer Specification

Two Mirna Clusters, Mir-34B/c and Mir-449, Are Essential for Normal Brain Development, Motile Ciliogenesis, and Spermatogenesis.

Microrna Expression Profiling of the Developing Mouse Heart.

MicroRNA-1 in Cardiac Diseases and Cancers.

Mirnas In Cardiac Development

Maternal Micrornas Are Essential For Mouse Zygotic Development